Riham M Bokhtia

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Venues

Molecules (Basel, Switzerland)

Molecular cancer therapeutics

Pharmaceuticals (Basel, Switzerland)

Zagazig University Faculty of Pharmacy

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Zagazig University Faculty of Pharmacy

Egypt

teaching assistant :: pharmaceutical organic chemistry

Publications

Juliette R Seremak, Kunj Bihari Gupta, Sunilkanth Bonigala, Elise Liu, Brendan Marshall, Wenbo Zhi, Riham M Bokhtia, Siva S Panda, Vinata B Lokeshwar, Vinata B Lokeshwar
Targeting Chemoresistance in Advanced Bladder Cancers with a Novel Adjuvant Strategy. Molecular cancer therapeutics (2024)
Juliette R Seremak, Kunj Bihari Gupta, Sunilkanth Bonigala, Elise Liu, Brendan Marshall, Wenbo Zhi, Riham M Bokhtia, Siva S Panda, Vinata B Lokeshwar, Vinata B Lokeshwar
Targeting Chemoresistance in Advanced Bladder Cancers with a Novel Adjuvant Strategy. Molecular cancer therapeutics (2024)
Riham M Bokhtia, Siva S Panda, Adel S Girgis, Nermin Samir, Mona F Said, Anwar Abdelnaser, Soad Nasr, Mohamed S Bekheit, Abdelhameed S Dawood, Horrick Sharma, Margaret Wade, Swapnil K Sharma, Amany M Ghanim
New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation. Molecules (Basel, Switzerland) 28 (4) (2023)
Riham M Bokhtia, Siva S Panda, Adel S Girgis, Nermin Samir, Mona F Said, Anwar Abdelnaser, Soad Nasr, Mohamed S Bekheit, Abdelhameed S Dawood, Horrick Sharma, Margaret Wade, Swapnil K Sharma, Amany M Ghanim
New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation. Molecules (Basel, Switzerland) 28 (4) (2023)
Riham M Bokhtia, Siva S Panda, Adel S Girgis, Nermin Samir, Mona F Said, Anwar Abdelnaser, Soad Nasr, Mohamed S Bekheit, Abdelhameed S Dawood, Horrick Sharma, Margaret Wade, Swapnil K Sharma, Amany M Ghanim
New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation. Molecules (Basel, Switzerland) 28 (4) (2023)
Riham M Bokhtia, Siva S Panda, Adel S Girgis, Nermin Samir, Mona F Said, Anwar Abdelnaser, Soad Nasr, Mohamed S Bekheit, Abdelhameed S Dawood, Horrick Sharma, Margaret Wade, Swapnil K Sharma, Amany M Ghanim
New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation. Molecules (Basel, Switzerland) 28 (4) (2023)
Riham M Bokhtia, Siva S Panda, Adel S Girgis, Nermin Samir, Mona F Said, Anwar Abdelnaser, Soad Nasr, Mohamed S Bekheit, Abdelhameed S Dawood, Horrick Sharma, Margaret Wade, Swapnil K Sharma, Amany M Ghanim
New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation. Molecules (Basel, Switzerland) 28 (4) (2023)
Riham M Bokhtia, Adel S Girgis, Tarek S Ibrahim, Fatma Rasslan, Eman S Nossier, Reham F Barghash, Rajeev Sakhuja, Eatedal H Abdel-Aal, Siva S Panda, Amany M M Al-Mahmoudy
Synthesis, Antibacterial Evaluation, and Computational Studies of a Diverse Set of Linezolid Conjugates. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Tarek S Ibrahim, Ehab S Taher, Ebtihal Samir, Azizah M Malebari, Ahdab N Khayyat, Mamdouh F A Mohamed, Riham M Bokhtia, Mohammed A AlAwadh, Israa A Seliem, Hani Z Asfour, Nabil Abdulhafiz Alhakamy, Siva S Panda, Amany M M Al-Mahmoudy
In Vitro Antimycobacterial Activity and Physicochemical Characterization of Diaryl Ether Triclosan Analogues as Potential InhA Reductase Inhibitors. Molecules (Basel, Switzerland) 25 (14) (2020)

Riham M Bokhtia.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Riham M Bokhtia